Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A systematic review of post-liver transplantation treatment and outcomes for late T-cell mediated, chronic ductopenic, and antibody-mediated rejection.

Hepatology communications·2026

Same author

Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer Risk.

Journal of gastroenterology and hepatology·2025

Same author

Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.

Gastroenterology·2025

Same author

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025

Same author

Donor-Recipient Race Mismatch Is Associated with Lower Survival After Liver Transplantation for Primary Sclerosing Cholangitis.

Journal of clinical medicine·2025

Same author

Second-Line but Not Second Rate: Fibrates for the Treatment of Patients with Primary Biliary Cholangitis.

Digestive diseases and sciences·2025

Search research articles

Related Experiment Video

Updated: Aug 9, 2025

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

Prognostic modeling in biliary diseases.

Camelia Ciobanu¹, Mark W Russo

¹Division of Hepatology, Atrium Health Wake Forest Baptist, Wake Forest University School of Medicine, Charlotte, North Carolina, USA.

Current Opinion in Gastroenterology

|February 23, 2023

Summary

This summary is machine-generated.

New prognostic models for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) offer improved predictions for patient outcomes. These tools aid in clinical trial design and patient risk assessment.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Related Experiment Videos

Last Updated: Aug 9, 2025

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Area of Science:

Hepatology
Internal Medicine
Clinical Trials

Background:

Cholestatic liver diseases, including primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), require accurate prognostic tools.
Existing models like alkaline phosphatase and Mayo Risk Score have limitations in predicting key clinical events.

Approach:

Review of noninvasive prognostic models for PSC and PBC.
Evaluation of models incorporating clinical data, imaging (elastography, MRI), and biochemical markers.
Comparison of model performance against established scores.

Key Points:

Advanced noninvasive models outperform traditional scores for predicting transplant-free survival and hepatic decompensation in PSC and PBC.
Specific PSC models include UK-PSC, PSC Risk Estimate Tool, and Amsterdam Oxford.
PBC models include UK-PBC, GLOBE score, and Paris II score.
Integration of elastography and MRI findings enhances prognostic accuracy.

Conclusions:

Noninvasive prognostic models provide valuable insights into patient risk for cholestatic diseases.
These models can serve as surrogate endpoints in clinical trials evaluating new therapeutic agents.